In just 4 months, AI medical scribe Abridge doubles valuation to $5.3B

Abridge, a pioneering AI startup focused on automating medical documentation, has successfully raised $300 million in a Series E funding round, propelling its valuation to an impressive $5.3 billion. This significant investment, reported by the Wall Street Journal, was spearheaded by Andreessen Horowitz, with notable contributions from Khosla Ventures. Just four months prior, Abridge secured $250 million in funding that valued the company at $2.75 billion. Founded seven years ago, Abridge has established itself as a frontrunner in the competitive AI medical scribe sector, thanks in part to its early market entry and integration with Epic Systems, a leading electronic health record provider. The company has also reported a remarkable $117 million in contracted annual recurring revenue for the first quarter, a figure that includes all signed recurring contracts, even from clients not yet onboarded. In addition to the latest funding, Abridge is set to enhance its offerings by converting medical notes from patient visits into AI-generated medical codes, positioning itself in direct competition with other startups like CodaMetrix and features from its partner, Epic Systems. Founded by cardiologist Shiv Rao, Abridge boasts a robust user base, claiming that over 150 of the largest healthcare systems across the United States utilize its AI scribe technology.